Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.

Area of Science:

• Proteomics
• Neuroimmunology
• Biomarker Discovery

Background:

• Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
• Relapsing-remitting MS (RRMS) is the most common form, characterized by distinct attacks and remissions.
• Identifying reliable biomarkers for RRMS is crucial for diagnosis and understanding disease pathogenesis.

Purpose of the Study:

• To identify proteins with differential abundance in cerebrospinal fluid (CSF) between RRMS patients and healthy controls.
• To discover potential diagnostic biomarkers for RRMS.
• To gain insights into the molecular mechanisms underlying RRMS pathogenesis.

Main Methods:

• Cerebrospinal fluid (CSF) samples from 17 RRMS patients and 17 controls were analyzed.
• Proteins were digested and analyzed using label-free liquid chromatography-mass spectrometry (LC-MS).
• Data analysis was performed using SearchGUI, PeptideShaker, and Progenesis software.

Main Results:

• A total of 291 proteins were identified in the CSF.
• 32 proteins showed significant differential abundance (P ≤ 0.05) between RRMS patients and controls.
• Included proteins previously associated with MS, such as immunoglobulin subunits and vitamin D-binding protein.

Conclusions:

• The study identified several differentially abundant proteins in the CSF of RRMS patients.
• These proteins represent potential biomarkers for RRMS diagnosis and therapeutic targets.
• Further validation in larger cohorts is necessary to confirm their clinical utility and role in disease pathogenesis.